Tapewire

NYSE · USD

PRGO

PERRIGO Co plc

Export transactions ↓
Tapewire entity
4516
SEC CIK
0001585364
Parsed reports
574

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 05, 2024 Filed Mar 8, 2024 02:10 UTC
Willis RobertEVP & CHRO
Exercise / conversionRestricted Stock Units · Derivative 1,279 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-24-000023 · wk-form4_1709863806.xml · derivative · entry 5

Willis Robert · CIK 0001770124 · EVP & CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 1,279 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:10 UTC
Willis RobertEVP & CHRO
Tax withholdingOrdinary Shares 3,792 $27.26 $103,369.92
Disclosure

SEC source: 0001585364-24-000023 · wk-form4_1709863806.xml · nonDerivative · entry 4

Willis Robert · CIK 0001770124 · EVP & CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,588

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:10 UTC
Willis RobertEVP & CHRO
GrantOrdinary Shares 7,291 $27.26 $198,752.66
Disclosure

SEC source: 0001585364-24-000023 · wk-form4_1709863806.xml · nonDerivative · entry 3

Willis Robert · CIK 0001770124 · EVP & CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,380

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:10 UTC
Willis RobertEVP & CHRO
Tax withholdingOrdinary Shares 666 $27.26 $18,155.16
Disclosure

SEC source: 0001585364-24-000023 · wk-form4_1709863806.xml · nonDerivative · entry 2

Willis Robert · CIK 0001770124 · EVP & CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,089

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:10 UTC
Willis RobertEVP & CHRO
Exercise / conversionOrdinary Shares 1,279 $27.26 $34,865.54
Disclosure

SEC source: 0001585364-24-000023 · wk-form4_1709863806.xml · nonDerivative · entry 1

Willis Robert · CIK 0001770124 · EVP & CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,755

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:00 UTC
Quinn GrainneEVP, Chief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 1,583 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-24-000021 · wk-form4_1709863230.xml · derivative · entry 5

Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 1,583 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:00 UTC
Quinn GrainneEVP, Chief Medical Officer
Tax withholdingOrdinary Shares 4,695 $27.26 $127,985.70
Disclosure

SEC source: 0001585364-24-000021 · wk-form4_1709863230.xml · nonDerivative · entry 4

Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,155

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:00 UTC
Quinn GrainneEVP, Chief Medical Officer
GrantOrdinary Shares 9,028 $27.26 $246,103.28
Disclosure

SEC source: 0001585364-24-000021 · wk-form4_1709863230.xml · nonDerivative · entry 3

Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,850

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:00 UTC
Quinn GrainneEVP, Chief Medical Officer
Tax withholdingOrdinary Shares 824 $27.26 $22,462.24
Disclosure

SEC source: 0001585364-24-000021 · wk-form4_1709863230.xml · nonDerivative · entry 2

Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,822

Read SEC document
March 05, 2024 Filed Mar 8, 2024 02:00 UTC
Quinn GrainneEVP, Chief Medical Officer
Exercise / conversionOrdinary Shares 1,583 $27.26 $43,152.58
Disclosure

SEC source: 0001585364-24-000021 · wk-form4_1709863230.xml · nonDerivative · entry 1

Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,646

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 01:31 UTC
Andersen SvendEVP & President CHCI
Exercise / conversionRestricted Stock Units · Derivative 0 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-24-000017 · wk-form4_1709861497.xml · derivative · entry 4

Andersen Svend · CIK 0001699722 · EVP & President CHCI

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,411

Underlying: Ordinary Shares · 0 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022.

Read SEC document
March 05, 2024 Filed Mar 8, 2024 01:31 UTC
Andersen SvendEVP & President CHCI
GrantOrdinary Shares 19,445 $27.26 $530,070.70
Disclosure

SEC source: 0001585364-24-000017 · wk-form4_1709861497.xml · nonDerivative · entry 3

Andersen Svend · CIK 0001699722 · EVP & President CHCI

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,597

Read SEC document
March 05, 2024 Filed Mar 8, 2024 01:31 UTC
Andersen SvendEVP & President CHCI
Exercise / conversionOrdinary Shares 3,411 $27.26 $92,983.86
Disclosure

SEC source: 0001585364-24-000017 · wk-form4_1709861497.xml · nonDerivative · entry 2

Andersen Svend · CIK 0001699722 · EVP & President CHCI

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2024 Filed Mar 1, 2024 19:31 UTC
Willis RobertEVP & CHRO
PurchaseOrdinary Shares 371 $26.30 $9,757.30
Disclosure

SEC source: 0001585364-24-000013 · wk-form4_1709321479.xml · nonDerivative · entry 2

Willis Robert · CIK 0001770124 · EVP & CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,476

Read SEC document
February 29, 2024 Filed Feb 29, 2024 18:39 UTC PurchaseOrdinary Shares 9,500 $26.54 $252,168.00
Disclosure

SEC source: 0001585364-24-000011 · wk-form4_1709231943.xml · nonDerivative · entry 1

Lockwood-Taylor Patrick · CIK 0001983899 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,500

Read SEC document
February 29, 2024 Filed Mar 1, 2024 19:31 UTC
Willis RobertEVP & CHRO
PurchaseOrdinary Shares 6,000 $25.87 $155,220.00
Disclosure

SEC source: 0001585364-24-000013 · wk-form4_1709321479.xml · nonDerivative · entry 1

Willis Robert · CIK 0001770124 · EVP & CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,105

Read SEC document
February 29, 2024 Filed Mar 8, 2024 02:54 UTC
Ives AlisonEVP & Chief Scientific Officer
PurchaseOrdinary Shares 1,545 $26.44 $40,849.80
Disclosure

SEC source: 0001585364-24-000029 · wk-form4_1709866449.xml · nonDerivative · entry 1

Ives Alison · CIK 0001932375 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,446

Read SEC document
November 24, 2023 Filed Nov 28, 2023 00:12 UTC
Willis RobertEVP & CHRO
PurchaseOrdinary Shares 5,550 $31.01 $172,105.50
Disclosure

SEC source: 0001585364-23-000152 · wk-form4_1701130327.xml · nonDerivative · entry 1

Willis Robert · CIK 0001770124 · EVP & CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,105

Read SEC document
November 16, 2023 Filed Nov 17, 2023 11:03 UTC
Ives AlisonEVP & Chief Scientific Officer
PurchaseOrdinary Shares 2,040 $29.34 $59,853.60
Disclosure

SEC source: 0001585364-23-000150 · wk-form4_1700218982.xml · nonDerivative · entry 1

Ives Alison · CIK 0001932375 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,380

Read SEC document
November 16, 2023 Filed Mar 8, 2024 02:47 UTC Amendment
Ives AlisonEVP & Chief Scientific Officer
PurchaseOrdinary Shares 2,040 $29.34 $59,853.60
Disclosure

SEC source: 0001585364-24-000027 · wk-form4a_1709866052.xml · nonDerivative · entry 1

Ives Alison · CIK 0001932375 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,901

F1 · balance_after: Due to an administrative error, the number of shares reported as owned following the transaction in the original filing was underreported by 521 shares.

Read SEC document
November 14, 2023 Filed Nov 15, 2023 00:12 UTC PurchaseOrdinary Shares 11,000 $28.99 $318,868.00
Disclosure

SEC source: 0001585364-23-000146 · wk-form4_1700007136.xml · nonDerivative · entry 1

Lockwood-Taylor Patrick · CIK 0001983899 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,000

Read SEC document
November 14, 2023 Filed Nov 15, 2023 17:14 UTC
Bezerra Eduardo GuaritaEVP & Chief Financial Officer
PurchaseOrdinary Shares 5,000 $29.18 $145,881.50
Disclosure

SEC source: 0001585364-23-000148 · wk-form4_1700068482.xml · nonDerivative · entry 1

Bezerra Eduardo Guarita · CIK 0001769771 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,428

Read SEC document
October 06, 2023 Filed Oct 10, 2023 20:58 UTC
Schmelter TrionaEVP & President CSCA
GrantRestricted Stock Units · Derivative 5,909 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-23-000135 · wk-form4_1696971497.xml · derivative · entry 3

Schmelter Triona · CIK 0001764458 · EVP & President CSCA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,909

Underlying: Ordinary Shares · 5,909 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 October 2024.

F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 October 2024.

Read SEC document
October 06, 2023 Filed Oct 10, 2023 20:58 UTC
Schmelter TrionaEVP & President CSCA
GrantRestricted Stock Units · Derivative 1,641 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-23-000135 · wk-form4_1696971497.xml · derivative · entry 2

Schmelter Triona · CIK 0001764458 · EVP & President CSCA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,641

Underlying: Ordinary Shares · 1,641 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 6 October 2024.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 6 October 2024.

Read SEC document
October 06, 2023 Filed Oct 10, 2023 12:23 UTC
Ives AlisonEVP & Chief Scientific Officer
Exercise / conversionRestricted Stock Units · Derivative 738 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-23-000132 · wf-form4_169694057748209.xml · derivative · entry 3

Ives Alison · CIK 0001932375 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 738 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · kind: Vesting of service-based restricted stock units granted on 7 October 2020.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 October 2021.

F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 October 2021.

Read SEC document
October 06, 2023 Filed Oct 10, 2023 12:23 UTC
Ives AlisonEVP & Chief Scientific Officer
Tax withholdingOrdinary Shares 217 $30.46 $6,609.82
Disclosure

SEC source: 0001585364-23-000132 · wf-form4_169694057748209.xml · nonDerivative · entry 2

Ives Alison · CIK 0001932375 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,861

Read SEC document
October 06, 2023 Filed Oct 10, 2023 12:23 UTC
Ives AlisonEVP & Chief Scientific Officer
Exercise / conversionOrdinary Shares 738 $30.46 $22,479.48
Disclosure

SEC source: 0001585364-23-000132 · wf-form4_169694057748209.xml · nonDerivative · entry 1

Ives Alison · CIK 0001932375 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,078

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Vesting of service-based restricted stock units granted on 7 October 2020.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 16:48 UTC Exercise / conversionRestricted Stock Units · Derivative 5,478 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-23-000128 · wf-form4_169229089334263.xml · derivative · entry 3

Manzone Albert · CIK 0001816333 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 5,478 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · kind: Vesting of service-based restricted stock units granted on 15 August 2022.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 August 2023.

F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 August 2023.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 16:48 UTC Tax withholdingOrdinary Shares 2,630 $38.88 $102,254.40
Disclosure

SEC source: 0001585364-23-000128 · wf-form4_169229089334263.xml · nonDerivative · entry 2

Manzone Albert · CIK 0001816333 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,848

Read SEC document
August 15, 2023 Filed Aug 17, 2023 16:48 UTC Exercise / conversionOrdinary Shares 5,478 $38.88 $212,984.64
Disclosure

SEC source: 0001585364-23-000128 · wf-form4_169229089334263.xml · nonDerivative · entry 1

Manzone Albert · CIK 0001816333 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,478

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Vesting of service-based restricted stock units granted on 15 August 2022.

Read SEC document
July 10, 2023 Filed Jul 12, 2023 16:36 UTC GrantRestricted Stock Units · Derivative 84,977 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-23-000116 · wf-form4_168917978736040.xml · derivative · entry 2

Lockwood-Taylor Patrick · CIK 0001983899 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,977

Underlying: Ordinary Shares · 84,977 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 10 July 2024.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 10 July 2024.

Read SEC document
July 07, 2023 Filed Jul 10, 2023 13:17 UTC
HANSON KYLEEVP & General Counsel
Exercise / conversionRestricted Stock Units · Derivative 2,677 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-23-000114 · wf-form4_168900946324482.xml · derivative · entry 6

HANSON KYLE · CIK 0001247708 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,352

Underlying: Ordinary Shares · 2,677 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F2 · kind: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 8 July 2023.

F3 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 8 July 2023.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 8 July 2023.

Read SEC document
July 07, 2023 Filed Jul 10, 2023 13:17 UTC
HANSON KYLEEVP & General Counsel
Exercise / conversionRestricted Stock Units · Derivative 9,732 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-23-000114 · wf-form4_168900946324482.xml · derivative · entry 5

HANSON KYLE · CIK 0001247708 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 9,732 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 8 July 2023.

F3 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 8 July 2023.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 8 July 2023.

Read SEC document
July 07, 2023 Filed Jul 10, 2023 13:17 UTC
HANSON KYLEEVP & General Counsel
Tax withholdingOrdinary Shares 786 $32.63 $25,647.18
Disclosure

SEC source: 0001585364-23-000114 · wf-form4_168900946324482.xml · nonDerivative · entry 4

HANSON KYLE · CIK 0001247708 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,766

Read SEC document
July 07, 2023 Filed Jul 10, 2023 13:17 UTC
HANSON KYLEEVP & General Counsel
Exercise / conversionOrdinary Shares 2,677 $32.63 $87,350.51
Disclosure

SEC source: 0001585364-23-000114 · wf-form4_168900946324482.xml · nonDerivative · entry 3

HANSON KYLE · CIK 0001247708 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,552

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 8 July 2023.

Read SEC document
July 07, 2023 Filed Jul 10, 2023 13:17 UTC
HANSON KYLEEVP & General Counsel
Tax withholdingOrdinary Shares 2,857 $32.63 $93,223.91
Disclosure

SEC source: 0001585364-23-000114 · wf-form4_168900946324482.xml · nonDerivative · entry 2

HANSON KYLE · CIK 0001247708 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,875

Read SEC document
July 07, 2023 Filed Jul 10, 2023 13:17 UTC
HANSON KYLEEVP & General Counsel
Exercise / conversionOrdinary Shares 9,732 $32.63 $317,555.16
Disclosure

SEC source: 0001585364-23-000114 · wf-form4_168900946324482.xml · nonDerivative · entry 1

HANSON KYLE · CIK 0001247708 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 8 July 2023.

Read SEC document
July 07, 2023 Filed Jul 10, 2023 17:18 UTC
Ives AlisonEVP & Chief Scientific Officer
Exercise / conversionRestricted Stock Units · Derivative 920 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-23-000115 · wf-form4_168900947961719.xml · derivative · entry 3

Ives Alison · CIK 0001932375 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,839

Underlying: Ordinary Shares · 920 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 8 July 2023.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 8 July 2023.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 8 July 2023.

Read SEC document
July 07, 2023 Filed Jul 10, 2023 17:18 UTC
Ives AlisonEVP & Chief Scientific Officer
Tax withholdingOrdinary Shares 271 $32.63 $8,842.73
Disclosure

SEC source: 0001585364-23-000115 · wf-form4_168900947961719.xml · nonDerivative · entry 2

Ives Alison · CIK 0001932375 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,340

Read SEC document
July 07, 2023 Filed Jul 10, 2023 17:18 UTC
Ives AlisonEVP & Chief Scientific Officer
Exercise / conversionOrdinary Shares 920 $32.63 $30,019.60
Disclosure

SEC source: 0001585364-23-000115 · wf-form4_168900947961719.xml · nonDerivative · entry 1

Ives Alison · CIK 0001932375 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,611

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 8 July 2023.

Read SEC document
June 13, 2023 Filed Jun 14, 2023 14:54 UTC PurchaseOrdinary Shares 10,000 $33.06 $330,637.00
Disclosure

SEC source: 0001585364-23-000106 · wf-form4_168675447611252.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Revocable Trust

Disclosed balance after: 25,879

F1 · ownership.nature: Revocable trust in which Geoffrey Parker and Jill Parker are the trustees.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 13:38 UTC
Bezerra Eduardo GuaritaEVP & Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 4,532 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-23-000104 · wf-form4_168631786993203.xml · derivative · entry 3

Bezerra Eduardo Guarita · CIK 0001769771 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,063

Underlying: Ordinary Shares · 4,532 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · kind: Vesting of service-based restricted stock units granted on 7 June 2022.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 June 2023.

F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 June 2023.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 13:38 UTC
Bezerra Eduardo GuaritaEVP & Chief Financial Officer
Tax withholdingOrdinary Shares 1,104 $33.72 $37,226.88
Disclosure

SEC source: 0001585364-23-000104 · wf-form4_168631786993203.xml · nonDerivative · entry 2

Bezerra Eduardo Guarita · CIK 0001769771 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,428

Read SEC document
June 07, 2023 Filed Jun 9, 2023 13:38 UTC
Bezerra Eduardo GuaritaEVP & Chief Financial Officer
Exercise / conversionOrdinary Shares 4,532 $33.72 $152,819.04
Disclosure

SEC source: 0001585364-23-000104 · wf-form4_168631786993203.xml · nonDerivative · entry 1

Bezerra Eduardo Guarita · CIK 0001769771 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,532

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Vesting of service-based restricted stock units granted on 7 June 2022.

Read SEC document
May 23, 2023 Filed May 25, 2023 12:16 UTC
Andersen SvendEVP & President CHCI
PurchaseOrdinary Shares 2,900 $33.41 $96,902.34
Disclosure

SEC source: 0001585364-23-000102 · wf-form4_168501699149589.xml · nonDerivative · entry 1

Andersen Svend · CIK 0001699722 · EVP & President CHCI

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,741

Read SEC document
May 17, 2023 Filed May 19, 2023 18:39 UTC Exercise / conversionRestricted Stock Units · Derivative 7,778 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-23-000098 · wf-form4_168452153521332.xml · derivative · entry 3

KINDLER JEFFREY B · CIK 0001174454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 7,778 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · kind: Vesting of service-based restricted stock units granted on 17 May 2022.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023.

F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023.

Read SEC document
May 17, 2023 Filed May 19, 2023 18:39 UTC Tax withholdingOrdinary Shares 3,734 $32.86 $122,699.24
Disclosure

SEC source: 0001585364-23-000098 · wf-form4_168452153521332.xml · nonDerivative · entry 2

KINDLER JEFFREY B · CIK 0001174454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,450

Read SEC document
May 17, 2023 Filed May 19, 2023 18:39 UTC Exercise / conversionOrdinary Shares 7,778 $32.86 $255,585.08
Disclosure

SEC source: 0001585364-23-000098 · wf-form4_168452153521332.xml · nonDerivative · entry 1

KINDLER JEFFREY B · CIK 0001174454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,184

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Vesting of service-based restricted stock units granted on 17 May 2022.

Read SEC document
May 17, 2023 Filed May 19, 2023 18:38 UTC Exercise / conversionRestricted Stock Units · Derivative 7,778 Not disclosed Not disclosed
Disclosure

SEC source: 0001585364-23-000096 · wf-form4_168452149168169.xml · derivative · entry 5

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 7,778 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · kind: Vesting of service-based restricted stock units granted on 17 May 2022.

F3 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F4 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023.

F4 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023.

Read SEC document
May 17, 2023 Filed May 19, 2023 18:38 UTC Tax withholdingOrdinary Shares 3,734 $32.86 $122,699.24
Disclosure

SEC source: 0001585364-23-000096 · wf-form4_168452149168169.xml · nonDerivative · entry 2

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,705

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.